No Increased Risk of Venous Thrombosis in Women Taking Tranexamic Acid

Thromb Haemost 2001; 86(02): 714-715
DOI: 10.1055/s-0037-1616122

Letters to the Editor

Schattauer GmbH

Erik Berntorp

¹Department for Coagulation Disorders, Lund University, Malmö University Hospital, Malmö, Sweden

,

Christina Follrud

¹Department for Coagulation Disorders, Lund University, Malmö University Hospital, Malmö, Sweden

,

Stefan Lethagen

¹Department for Coagulation Disorders, Lund University, Malmö University Hospital, Malmö, Sweden

References
1 Ogston D. Antifibrinolytic drugs; chemistry, pharmacology and clinical usage. John Wiley & Sons; 1984
2 Reynolds JEF. (ed). Martindale; The extra pharmacopoeia. London: Royal Pharmaceutical Society; 1996
3 Dunn CJ, Goa KL. Tranexamic acid. A review of its use in surgery and other indications. Drugs 1999; 57 (Suppl. 06) 1005-32.
4 Royal College of Obstetricians and Gynaecologists.. The initial management of menorrhagia. Evidence-based clinical guidelines No. 1. RCOG Press; 1998. pp 1-43.
5 Cooke I, Lethaby A, Farquhar C. Antifibrinolytics for heavy menstrual bleeding (Cochrane Review). In: The Cochrane Library. Issue 3 2000. Oxford: Update Software.
6 Statistisk årsbok för Sverige 2000. Statistiska centralbyrån 2000; 86: 59.
7 National Corporation of Pharmacies in Sweden. 2000